Evidence map›Paper›PMID 37464342›Full record

ArticleBMC psychiatry2023

Low cognitive functioning and depressive symptoms in patients with rheumatoid arthritis and systemic sclerosis: a clinical study.

Panagiotis Alexopoulos, Maria Skondra, Marina Charalampopoulou, Eliza Eleni-Zacharoula Georgiou, Antonios Alexandros Demertzis, Suzana Ιoanna Aligianni, Philippos Gourzis, Antonios Politis, Polychronis Εconomou, Dimitrios Daoussis

Open access · goldAbstract read
In one paragraph

Article in BMC psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Panagiotis Alexopoulos *Mental Health Services, Department of Medicine, School of Health Sciences, Patras University Hospital, University of Patras, Rion 26504, Patras, Greece. panos.alexopoulos@upatras.gr.
Maria Skondra *Mental Health Services, Department of Medicine, School of Health Sciences, Patras University Hospital, University of Patras, Rion 26504, Patras, Greece.
Marina CharalampopoulouMental Health Services, Department of Medicine, School of Health Sciences, Patras University Hospital, University of Patras, Rion 26504, Patras, Greece.
Eliza Eleni-Zacharoula GeorgiouMental Health Services, Department of Medicine, School of Health Sciences, Patras University Hospital, University of Patras, Rion 26504, Patras, Greece.
Antonios Alexandros DemertzisMental Health Services, Department of Medicine, School of Health Sciences, Patras University Hospital, University of Patras, Rion 26504, Patras, Greece.
Suzana Ιoanna AligianniMental Health Services, Department of Medicine, School of Health Sciences, Patras University Hospital, University of Patras, Rion 26504, Patras, Greece.
Philippos GourzisMental Health Services, Department of Medicine, School of Health Sciences, Patras University Hospital, University of Patras, Rion 26504, Patras, Greece.
Antonios PolitisFirst Department of Psychiatry, Eginition Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Polychronis ΕconomouDepartment of Civil Engineering (Statistics), School of Engineering, University of Patras, Patras, Greece.
Dimitrios DaoussisDepartment of Rheumatology, University of Patras Medical School, Patras, Greece.
University of Patras · GRJohns Hopkins University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecently, cognitive deficits occurring in rheumatic diseases have attracted scientific attention. Cognitive symptoms in patients with Rheumatoid Arthritis (RA) and Systemic Sclerosis (SSc) have not been thoroughly studied. This study aimed to assess cognitive function and its relationship with depressive symptoms in RA and SSc and compare it to mild neurocognitive disorder due to Alzheimer's disease (MiND) and to individuals without cognitive impairment.

methodsCognitive function and depressive symptoms were tapped with the Cognitive Telephone Screening Instrument plus (COGTEL+), the Serial Seven Test (SST), the Mini-Mental State Examination (MMSE) and the Geriatric Depression scale-15 (GDS), respectively. Statistical analyses included between groups-, correlation- and regression analyses. Demographic characteristics were considered in the regression models.

resultsThe study included 30 individuals with RA, 24 with SSc, 26 adults without cognitive impairment and 33 individuals with MiND. Lower performance in verbal short-term memory, concentration/attention, verbal fluency and MMSE in patients with RA compared to individuals without cognitive impairment was detected. Of note, performance on verbal fluency, concentration/attention, inductive reasoning and MMSE was lower in RA compared to MiND. Individuals with SSc performed worse in verbal fluency and in MMSE in comparison to adults without cognitive deficits. Verbal fluency deficits in SSc exceeded that in MiND. Performance on MMSE, COGTEL+, prospective memory, working memory, verbal fluency and concentration/attention was related to GDS scores, which did not vary across the groups.

conclusionsPatients with RA and SSc encountered cognitive dysfunction, which partially pertains to depressive symptoms. Of note, the severity of cognitive dysfunction in many cases exceeded that of MiND.

Indexed as

Arthritis, RheumatoidCognition DisordersCognitive DysfunctionAdultAgedCognitionDepressionHumansNeuropsychological TestsConcentration/attentionInductive reasoningShort-term memoryVerbal fluency

Identifiers

PMID37464342
PMCPMC10355084
OpenAlexW4384663260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.